Engineered PRINT^® nanoparticles for controlled delivery of antigens and immunostimulants

References

• Smith DM, Simon JK, Baker JR Jr.. Applications of nanotechnology for immunology. Nat Rev Immunol 2013; 13:592 - 605; http://dx.doi.org/10.1038/nri3488; PMID: 23883969
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Plotkin SL. The development of vaccines: how the past led to the future. Nat Rev Microbiol 2011; 9:889 - 93; http://dx.doi.org/10.1038/nrmicro2668; PMID: 21963800
   PubMed Web of Science ®Google Scholar
• Levine MM, Sztein MB. Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 2004; 5:460 - 4; http://dx.doi.org/10.1038/ni0504-460; PMID: 15116108
   PubMed Web of Science ®Google Scholar
• Irvine DJ, Swartz MA, Szeto GL. Engineering synthetic vaccines using cues from natural immunity. Nat Mater 2013; 12:978 - 90; http://dx.doi.org/10.1038/nmat3775; PMID: 24150416
   PubMed Web of Science ®Google Scholar
• Perry JL, Herlihy KP, Napier ME, Desimone JM. PRINT: a novel platform toward shape and size specific nanoparticle theranostics. Acc Chem Res 2011; 44:990 - 8; http://dx.doi.org/10.1021/ar2000315; PMID: 21809808
   PubMed Web of Science ®Google Scholar
• Galloway AL, Murphy A, DeSimone JM, Di J, Herrmann JP, Hunter ME, Kindig JP, Malinoski FJ, Rumley MA, Stoltz DM, et al. Development of a nanoparticle-based influenza vaccine using the PRINT technology. Nanomedicine 2013; 9:523 - 31; http://dx.doi.org/10.1016/j.nano.2012.11.001; PMID: 23178283
   PubMed Web of Science ®Google Scholar
• Euliss LE, DuPont JA, Gratton S, DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem Soc Rev 2006; 35:1095 - 104; http://dx.doi.org/10.1039/b600913c; PMID: 17057838
   PubMed Web of Science ®Google Scholar
• Kelly JY, DeSimone JM. Shape-specific, monodisperse nano-molding of protein particles. J Am Chem Soc 2008; 130:5438 - 9; http://dx.doi.org/10.1021/ja8014428; PMID: 18376832
   PubMed Web of Science ®Google Scholar
• Dunn SS, Tian S, Blake S, Wang J, Galloway AL, Murphy A, Pohlhaus PD, Rolland JP, Napier ME, DeSimone JM. Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. J Am Chem Soc 2012; 134:7423 - 30; http://dx.doi.org/10.1021/ja300174v; PMID: 22475061
   PubMed Web of Science ®Google Scholar
• Hasan W, Chu K, Gullapalli A, Dunn SS, Enlow EM, Luft JC, Tian S, Napier ME, Pohlhaus PD, Rolland JP, et al. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer. Nano Lett 2012; 12:287 - 92; http://dx.doi.org/10.1021/nl2035354; PMID: 22165988
   PubMed Web of Science ®Google Scholar
• Garcia A, Mack P, Williams S, Fromen C, Shen T, Tully J, Pillai J, Kuehl P, Napier M, DeSimone JM, et al. Microfabricated Engineered Particle Systems for Respiratory Drug Delivery and Other Pharmaceutical Applications. J Drug Deliv. 2012; 2012:941243
   PubMedGoogle Scholar
• Xu J, Luft JC, Yi X, Tian S, Owens G, Wang J, Johnson A, Berglund P, Smith J, Napier ME, et al. RNA replicon delivery via lipid-complexed PRINT protein particles. Mol Pharm 2013; 10:3366 - 74; http://dx.doi.org/10.1021/mp400190z; PMID: 23924216
   PubMed Web of Science ®Google Scholar
• Xu J, Wang J, Luft JC, Tian S, Owens G Jr., Pandya AA, Berglund P, Pohlhaus P, Maynor BW, Smith J, et al. Rendering protein-based particles transiently insoluble for therapeutic applications. J Am Chem Soc 2012; 134:8774 - 7; http://dx.doi.org/10.1021/ja302363r; PMID: 22568387
   PubMed Web of Science ®Google Scholar
• Chen K, Merkel TJ, Pandya A, Napier ME, Luft JC, Daniel W, Sheiko S, DeSimone JM. Low modulus biomimetic microgel particles with high loading of hemoglobin. Biomacromolecules 2012; 13:2748 - 59; http://dx.doi.org/10.1021/bm3007242; PMID: 22852860
   PubMed Web of Science ®Google Scholar
• Chu KS, Schorzman AN, Finniss MC, Bowerman CJ, Peng L, Luft JC, Madden AJ, Wang AZ, Zamboni WC, DeSimone JM. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials 2013; 34:8424 - 9; http://dx.doi.org/10.1016/j.biomaterials.2013.07.038; PMID: 23899444
   PubMed Web of Science ®Google Scholar
• Chu KS, Hasan W, Rawal S, Walsh MD, Enlow EM, Luft JC, Bridges AS, Kuijer JL, Napier ME, Zamboni WC, et al. Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine 2013; 9:686 - 93; http://dx.doi.org/10.1016/j.nano.2012.11.008; PMID: 23219874
   PubMed Web of Science ®Google Scholar
• Parrott MC, Finniss M, Luft JC, Pandya A, Gullapalli A, Napier ME, DeSimone JM. Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles. J Am Chem Soc 2012; 134:7978 - 82; http://dx.doi.org/10.1021/ja301710z; PMID: 22545784
   PubMed Web of Science ®Google Scholar
• Leleux J, Roy K. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv Healthc Mater 2013; 2:72 - 94; http://dx.doi.org/10.1002/adhm.201200268; PMID: 23225517
   PubMed Web of Science ®Google Scholar
• Doherty PC, Turner SJ, Webby RG, Thomas PG. Influenza and the challenge for immunology. Nat Immunol 2006; 7:449 - 55; http://dx.doi.org/10.1038/ni1343; PMID: 16622432
   PubMed Web of Science ®Google Scholar
• Regules JA, Cummings JF, Ockenhouse CF. The RTS,S vaccine candidate for malaria. Expert Rev Vaccines 2011; 10:589 - 99; http://dx.doi.org/10.1586/erv.11.57; PMID: 21604980
   PubMed Web of Science ®Google Scholar
• Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001; 20:1105 - 7
   PubMed Web of Science ®Google Scholar
• Astronomo RD, Burton DR. Carbohydrate vaccines: developing sweet solutions to sticky situations?. Nat Rev Drug Discov 2010; 9:308 - 24; http://dx.doi.org/10.1038/nrd3012; PMID: 20357803
   PubMed Web of Science ®Google Scholar
• Frasch CE. Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges. Vaccine 2009; 27:6468 - 70; http://dx.doi.org/10.1016/j.vaccine.2009.06.013; PMID: 19555714
   PubMed Web of Science ®Google Scholar
• Swartz MA, Hirosue S, Hubbell JA. Engineering approaches to immunotherapy. Sci Transl Med. 2012; 4:148rv9
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 2009; 26:244 - 9; http://dx.doi.org/10.1007/s11095-008-9626-z; PMID: 18548338
   PubMed Web of Science ®Google Scholar
• Roberts RA, Shen T, Allen IC, Hasan W, DeSimone JM, Ting JP. Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles. PLoS One 2013; 8:e62115; http://dx.doi.org/10.1371/journal.pone.0062115; PMID: 23593509
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012; 64:1547 - 68; http://dx.doi.org/10.1016/j.addr.2012.04.005; PMID: 22575858
   PubMed Web of Science ®Google Scholar
• Wang J, Tian S, Petros RA, Napier ME, Desimone JM. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc 2010; 132:11306 - 13; http://dx.doi.org/10.1021/ja1043177; PMID: 20698697
   PubMed Web of Science ®Google Scholar
• Jordan MB, Mills DM, Kappler J, Marrack P, Cambier JC. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 2004; 304:1808 - 10; http://dx.doi.org/10.1126/science.1089926; PMID: 15205534
   PubMed Web of Science ®Google Scholar
• Jones SW, Roberts RA, Robbins GR, Perry JL, Kai MP, Chen K, Bo T, Napier ME, Ting JPY, Desimone JM, et al. Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest 2013; 123:3061 - 73; http://dx.doi.org/10.1172/JCI66895; PMID: 23778144
   PubMed Web of Science ®Google Scholar
• Moga KA, Bickford LR, Geil RD, Dunn SS, Pandya AA, Wang Y, Fain JH, Archuleta CF, O’Neill AT, Desimone JM. Rapidly-dissolvable microneedle patches via a highly scalable and reproducible soft lithography approach. Adv Mater 2013; 25:5060 - 6; http://dx.doi.org/10.1002/adma.201300526; PMID: 23893866
   PubMed Web of Science ®Google Scholar